Mettler-Toledo International (NYSE:MTD) Price Target Raised to $1,600.00

Mettler-Toledo International (NYSE:MTD) had its price objective raised by Citigroup from $1,400.00 to $1,600.00 in a report issued on Thursday morning,Benzinga reports. The firm currently has a buy rating on the medical instruments supplier’s stock.

MTD has been the topic of several other research reports. Jefferies Financial Group upgraded Mettler-Toledo International from an “underperform” rating to a “hold” rating and cut their price target for the stock from $1,200.00 to $1,110.00 in a report on Monday, May 5th. Wells Fargo & Company increased their price target on Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the stock an “equal weight” rating in a report on Monday, May 5th. UBS Group upgraded Mettler-Toledo International from a “neutral” rating to a “buy” rating and cut their price target for the stock from $1,530.00 to $1,350.00 in a report on Tuesday, May 20th. Evercore ISI dropped their target price on Mettler-Toledo International from $1,280.00 to $1,275.00 and set an “outperform” rating on the stock in a report on Monday, August 4th. Finally, Robert W. Baird raised their target price on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the company a “neutral” rating in a report on Monday, August 4th. Five investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $1,311.11.

Mettler-Toledo International Stock Performance

Shares of NYSE:MTD opened at $1,320.4310 on Thursday. The business’s 50 day simple moving average is $1,227.64 and its two-hundred day simple moving average is $1,187.91. The firm has a market cap of $27.20 billion, a P/E ratio of 33.44, a PEG ratio of 3.97 and a beta of 1.34. Mettler-Toledo International has a 52-week low of $946.69 and a 52-week high of $1,521.01.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $9.58 by $0.51. The business had revenue of $983.22 million for the quarter, compared to analyst estimates of $957.41 million. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The company’s quarterly revenue was up 3.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $9.65 earnings per share. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. On average, equities analysts forecast that Mettler-Toledo International will post 42.71 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, Director Michael A. Kelly sold 1,062 shares of Mettler-Toledo International stock in a transaction on Wednesday, May 28th. The stock was sold at an average price of $1,159.93, for a total transaction of $1,231,845.66. Following the sale, the director directly owned 120 shares in the company, valued at approximately $139,191.60. This trade represents a 89.85% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Thomas P. Salice sold 1,062 shares of Mettler-Toledo International stock in a transaction on Wednesday, August 13th. The stock was sold at an average price of $1,300.90, for a total value of $1,381,555.80. Following the sale, the director owned 283 shares in the company, valued at $368,154.70. This trade represents a 78.96% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 2,889 shares of company stock worth $3,603,054 over the last three months. Company insiders own 1.94% of the company’s stock.

Institutional Trading of Mettler-Toledo International

Hedge funds have recently bought and sold shares of the business. WPG Advisers LLC bought a new stake in Mettler-Toledo International during the first quarter worth $41,000. NewSquare Capital LLC lifted its holdings in Mettler-Toledo International by 94.4% during the second quarter. NewSquare Capital LLC now owns 35 shares of the medical instruments supplier’s stock worth $41,000 after acquiring an additional 17 shares during the period. Zions Bancorporation National Association UT bought a new stake in Mettler-Toledo International during the first quarter worth $43,000. MV Capital Management Inc. lifted its holdings in Mettler-Toledo International by 50.0% during the second quarter. MV Capital Management Inc. now owns 36 shares of the medical instruments supplier’s stock worth $42,000 after acquiring an additional 12 shares during the period. Finally, Golden State Wealth Management LLC lifted its holdings in Mettler-Toledo International by 583.3% during the first quarter. Golden State Wealth Management LLC now owns 41 shares of the medical instruments supplier’s stock worth $48,000 after acquiring an additional 35 shares during the period. 95.07% of the stock is currently owned by institutional investors.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.